Battelle and Canopy Growth work together to advance knowledge surrounding cannabis in support of medical research and novel product development. Canopy Growth and Battelle completed the rigorous federal approval process required to import cannabis products into the United States and since October 9th, the organizations have completed multiple product transfers to Battelle’s secure research facilities pursuant to United States Drug Enforcement Agency approvals. For decades, Battelle scientists have developed methods for testing a variety of controlled substances as well as employing analytical chemistry services for government and private industry. Notably, product transfers have consisted of a variety of cannabis form factors, including dried cannabis and Canopy Growth’s precisely dosed Softgels.
Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries.